Clinical trial
Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or…
NCT00012181 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00012181 |
|---|---|
| Title | Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas |
| Official title | A PHASE I STUDY OF FLAVOPIRIDOL (NSC# 649890; IND# 46211) IN PATIENTS WITH RELAPSED OR REFRACTORY PEDIATRIC SOLID TUMORS OR LYMPHOMAS |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Ependymoma, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Malignant Germ Cell Tumor, Recurrent Childhood Medulloblastoma, Recurrent Childhood Rhabdomyosarcoma and 13 more |
| Intervention type | Drug, Other |
| Interventions | alvocidib, pharmacological study |
| Enrollment | 30 |
| Start date | Apr 1, 2001 |
| Primary completion | Jan 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 2, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: